Skip to content

Color-dependent Melatonin Suppression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02936674
Enrollment
10
Registered
2016-10-18
Start date
2016-10-31
Completion date
2017-06-30
Last updated
2018-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melatonin

Brief summary

The purpose of this study is to examine the effects of complex, broad-band spectra light on the production of melatonin in humans.

Interventions

DEVICELight - standard

Light will be given during the night to determine its effects on melatonin suppression. This light will be an LED with standard spectral distribution

DEVICELight - alternate

Light will be given during the night to determine its effects on melatonin suppression. This light will be an LED with an altered spectral distribution (different color)

Sponsors

VA Palo Alto Health Care System
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Stable health * Normal color vision * Normal hearing * 18-35 years old

Exclusion criteria

* Significant depressive symptoms * Pregnant or nursing * Ocular pathologies * Unstable or severe medical or psychiatric condition * Extreme morning/evening type * Regular smoker * Use of medications that impact ocular function * Alcohol use disorder * Use of illegal drugs * Irregular use of antihistamines, antidepressants, or sleeping medications

Design outcomes

Primary

MeasureTime frameDescription
Melatonin suppression4 HoursThe amount of declination of salivary melatonin concentrations between the start of the light and the end of the light (4 hours later) will be compared between the conditions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026